| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  INCREDIBLE® (formerly JuiceInnov8) Building the next generation of food & beverage that are healthier for everyone and greater for this planet—with biology INCREDIBLE® BIO (formerly JuiceInnov8) was founded under the mission to build the next generation of food & beverage that is healthier for everyone and greater for this planet (and perhaps, Mars) with the power of biology. We are a food-biotechnology startup, born and bred by engineers, scientists, marketers, challengers, and rebels who're crazy enough to believe that we can make things we eat & drink beyond just better. We harness the power of nature with a twist of science to create … Type: | 0 | 0 | 0 | 19 |
 | X-ZELL Enabling same-day cancer diagnostics from minimally invasive sample material X-ZELL is an award-winning medical technology start-up specialising in next-generation cytology. Cytology – or cytopathology – is the science of diagnosing diseases by examining single atypical cells or cell clusters. X-ZELL has developed a plug-and-play solution for the detection, visualization and digitization of these phenomena in minimally invasive body liquids. Slotting seamlessly into clinical routine, it does not require complex specimen preparation and reduces the average time from sample to diagnosis from 48h to less than 4h. The result: better diagnostics and improved patient care. X-ZELL is headquartered in Singapore and … Type: | 8 | 0 | 8 | 19 |
 |  Anuva Creating the world’s most diverse Genomic Bio/Data Bank to help uncover novel biological pathways for drug discovery Anuva is creating the world’s most diverse Genomic Bio/Data Bank to help uncover novel biological pathways for drug discovery. Anuva is a translational research company that is creating the most diverse Genomic Bio/Data Bank of Asian Populations, which is being utilized for research & development within the pharma industry. Our cohorts and biorepository allow for follow-on clinical and translational studies, which greatly empower drug development opportunities. IndiaCHIP, Genomics, Genomics - Emerging markets, Genomics - R&D, Genomics Data Platform, Genomics - India, bioinformatics, and … Type: | 8 | 2 | 6 | 61 |
 | Cilcare MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, … Type: | 43 | 13 | 39 | 48 |
 | IDMED Innovative technology, safer outcomes. IDMED, a French company based in Marseille, develops and markets innovative medical devices in the fields of anesthesia and intensive care. Our products are used worldwide in operating theaters, intensive care units, neuro-ophthalmological consultations and research laboratories. Our products are commonly used in the areas of pupillometry, neuromuscular blockade monitoring and analgesia monitoring. IDMED develops products in collaboration with healthcare professionals. Innovation, reliability and relevance are the core qualities of our devices. We put our technical knowledge to the service of an improved everyday clinical practice. Healthcare, Medical device, Anaesthesiology, Medical technology, ICU, Pupillometry, and Analgesia … Type: | 5 | 3 | 3 | 29 |
 | PhysioAssist [Automatic translation follows] PhysioAssist develops and markets Simeox, an innovative airway clearance device for patients with CF, COPD, BE PhysioAssist is a medical equipment company that has developed expertise in rheology, the study of the physics of bronchial mucus. After several years of research, an effective pneumatic vibration signal has been characterized to act on intrapulmonary mucus, liquefy it and drain it. This signal is delivered by the Simeox medical device, which stimulates bronchial mucus by successive depressions, while ensuring passive expiration. Simeox is intended for patients with chronic respiratory diseases. COPD, airway clearance, respiratory device, and cystic fibrosis Type: | 6 | 4 | 0 | 15 |
 |  FineHeart A Healthier Life With Every Beat FineHeart is a clinical stage medical device company based in Bordeaux, France. Its innovative product, FLOWMAKER®, has the potential to treat 200,000 patients with advanced heart failure each year. FineHeart will initially target the 50,000 most severe patients who are eligible for cardiac assistance. Initial estimates value this market segment to be worth over US$5 billion. FineHeart was founded by CEO Arnaud Mascarell and a team of internationally renowned cardiac surgeons and electro-physiologists, including Dr. Stephane Garrigue, CSO and inventor of the concept, and Dr. Philippe Ritter, co-inventor of cardiac resynchronization therapy (CRT). The … Type: | 29 | 11 | 24 | 73 |
 | Coave Therapeutics Coave therapeutics Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet need and where success … Type: | 8 | 5 | 2 | 39 |
 | Redberry SAS Industrial microbiology testing providing immediate results at performance and ease-of-use never reached before. Redberry offers rapid testing solutions aimed at avoiding the culture phase of microorganisms in industrial microbiology and thus providing immediate results at cost, performance and ease-of-use never reached before. We work with Pharmaceutical and Personal Care Product manufacturers. We also offer solutions for Water professionals and collectivities. Available applications : ►ATMP Release testing : Rapid 3-Level Approach ►Sterility testing for Pharma Products : 4 days results with full compendial sample preparation - Primary validation package available with full equivalency. ►Rapid Bioburden for in-process, raw materials, final products … Type: | 24 | 10 | 17 | 20 |
 | CEMENTIC Nano Life Sciences Cementic, founded in 2016, is a pioneering biotech startup with bases in Paris, France, and Palo Alto, USA. Specializing in cutting-edge nano-biotechnology solutions, our focus is on revolutionizing healthcare through innovative applications in dental care, orthopedics, and stem cell research. We leverage new paradigms to address complex health challenges, advancing global health from our dual locations. Medtech, Biotech, Dental, Orthopedics, Nanotechnolgies, Stem cells , and Liposomes Type: | 0 | 0 | 0 | 3 |
 | AlgoTx AlgoTx develops novel therapeutic solutions for complex pain AlgoTx is a clinical stage biotechnology company developing targeted, first in class therapeutics for peripheral neuropathic pain. Non-opioid, locally acting ATX01 is designed to treat the pain of Chemotherapy-Induced Peripheral Neuropathy, a common and painful side-effect of cancer treatments. It targets the signaling pathways involved in the regulation of pain by selectively inhibiting specific nociceptive sodium channel receptors. FDA granted ATX01 Fast-Track designation. The ACT study is an international Phase II randomized, placebo-controlled trial involving over 270 patients ; The results will be available in early 2025 and the company is making … Type: | 4 | 3 | 2 | 10 |
 | Implanet The permanent balance Based near Bordeaux (FR), IMPLANET is an international company with a US subsidiary in Boston, funded by European institutional and private investors. IMPLANET focuses on spine and knee products. Its flagship product, the JazzTM latest generation implant, is intended to improve the treatment of spinal disorders requiring spinal fusion surgery. Protected by 4 sets of international patents, JazzTM has obtained 510(k) clearance from the Food and Drug Administration (FDA) in the United States and the CE mark. Taking into account the evolution of the global healthcare system, the IMPLANET Marketing team identifies a portfolio of products and … Type: | 0 | 0 | 0 | 41 |
 | POXEL Poxel is a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare disorders. Poxel has clinical and earlier-stage programs from its adenosine monophosphate-activated protein kinase (AMPK) activator and deuterated TZD platforms targeting chronic and rare metabolic diseases. For the treatment of NASH, PXL065 (deuterium-stabilized R-pioglitazone) is in a streamlined Phase 2 trial (DESTINY1). PXL770, a first-in-class direct AMPK activator, has successfully completed a Phase 2a proof-of-concept trial for the treatment of NASH, which met its objectives. For the rare inherited metabolic disorder, adrenoleukodystrophy (ALD), the company intends to initiate … Type: | 2 | 2 | 0 | 26 |
 | SIGNIA THERAPEUTICS Breakthrough Solution for Respiratory Infections SIGNIA THERAPEUTICS is a research company based out of Bâtiment Adénine, 60 Avenue Rockefeller, 69008 Lyon, France Type: | 0 | 0 | 0 | 5 |
 | Drepacare [Automatic translation follows] Drepacare is the first mobile application for #sickle cell patients. Sickle cell disease is the most widespread genetic disease in the world, 50 million people are affected, including 12,000 in France. Created in 2016 by three entrepreneurs/students in Master of Nutrition and Public Health in parallel with their careers as pharmacists, nurses and biotechnology engineers, its aim is to make the daily lives of patients easier with features that help manage treatments, diet, frequency of crises, and hospitalizations. The idea is based on the observation of a great lack of communication and information on sickle cell disease, … Type: | 12 | 3 | 5 | 5 |
 | ErgoSanté ERGONOMICS FOR ALL ErgoSanté is a company specialized in the design, manufacturing, and distribution of customized ergonomic solutions aimed at maintaining employment for workers with disabilities and preventing musculoskeletal disorders (MSDs) risks. ErgoSanté distributes its products both nationally and worldwide. Our approach is unique: once your needs have been identified by healthcare professionals (such as occupational physicians, ergonomists, or employment support advisors), we lend you the recommended equipment for free so that you can judge the effectiveness of the proposed solution for yourself. We cater to both seated employees (with ergonomic chairs, height-adjustable desks, and accessories) and standing employees (with … Type: | 68 | 10 | 57 | 167 |
 | PrediSurge Precision Medicine Platform for Cardiovascular Interventions PrediSurge develops a precision medicine platform to assist physicians in better planning their endovascular interventions. Based on pre-operative imaging, our technology enables creation of patient-specific digital twins: numerical models simulating arteries and valves biomechanical behavior. In a clinical context, these digital models can be used to numerically investigate different device implantation approaches and to determine the best strategy for a specific patient. In an industrial context, use of digital twins boosts innovative product development by early de-risking of avant-garde technologies, compressing design iteration period and early prediction of in-vivo performances. It’s a cost-effective solution … Type: | 18 | 10 | 11 | 31 |
 | Continuum Plus Santé [Automatic translation follows] Reinventing the monitoring of patients under anticancer drugs #AKOadom, Continuum+ Connect Telemonitoring Platform Closer to patients. cancer, health, digital, E-health, Home support, and telemonitoring Type: | 39 | 8 | 34 | 21 |
 | Aenitis Technologies Acoustic Cell Processing Solution 🚀 Aenitis designs, develops, and markets sole-in-class acoustofluidic technology that makes cell and gene therapy manufacturing better, safer, and less expensive. By precisely controlling levitated cells with sound waves, our systems handle cells in full sterile conditions and radically increase productivity while preserving the native state of cells at every step of the engineering process. This technology enables gentle, non-invasive manipulation of cells at the millifluidic scale, allowing for the handling of tens of milliliters per minute. Such capabilities are critical for scaling applications from research to clinical and industrial use. 💡Today, we have achieved proof-of-concepts … Type: | 22 | 5 | 18 | 16 |
 | BioAxial, part of Telight Explore the Unseen BioAxial is now part of Telight. Please follow our news at Telight LinkedIn page https://linkedin.com/company/telight TELIGHT specializes in a field of instruments employing light optics, in particular, providing innovative types and solutions for light microscopy. Super Resolution Microscopy, Fluorescence Microscopy, Conical Diffraction Optical Components, Nanoscopy, Living Cell Imaging, Low phototoxicity, Standard Workflow, Multicolor Imaging, and Intuitive Type: | 3 | 1 | 0 | 10 |
 | InBrain Pharma InBrain Pharma, a CNS disorders focused biotech, founded in 2018, exploiting through an exclusive worldwide patent license signed with the Northern France TTO, a groundbreaking therapeutic approach of advanced Parkinson’s Disease based on the research work of Pr David DEVOS and Pr Caroline MOREAU developed within their academic research Team from the Université́ de Lille, Lille Neuroscience & cognition UMR-S 1172 INSERM and the Lille University Hospital. To date, the company has raised €4.4 million in dilutive and non-dilutive financing, these funds having enabled to carry out a first phase I/IIb DIVE-I clinical trial on 12 patients, for which results … Type: | 15 | 6 | 10 | 4 |
 | BioC3 Synthetic Biology BioC3 is a French biotech startup that has created an innovative biocatalysis platform. This brings standardized and highly efficient reaction cascades thanks to stabilized enzymes. The reactions take place in water at ambient temperature and atmospheric pressure, using carbon sources that are renewable. No polluting by-product is generated. Type: | 0 | 0 | 0 | 11 |
 | Five Lives Add Life to Years. We build Digital Therapeutics for better risk assessment & prevention of dementia. Five Lives is a Digital Therapeutics start-up developing “Five Lives”, a direct-to-consumer brain health mobile app to help everyone measure and reduce their risk of dementia through an improved lifestyle. Type: | 14 | 7 | 8 | 23 |
 | DIAG2TEC Preclinical CRO in Hematological Cancers Diag2Tec is an expert preclinical CRO devoted to hematological cancers, especially Multiple Myeloma (MM). We focused on in vitro Drug Testing in Human Hematological Cancer derived Cell Lines and Primary Cells from patients with various Hematologic Malignancies (Multiple Myeloma, Diffuse Large B Cells Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Mantle cell Lymphoma, Chronic Lymphoid Leukemia...). With our 2 platforms : Drug Testing Services and ChimioFx, our mission is to provide efficient treatment solutions for patients suffering from Hematological Malignancies with Precision Medicine approaches. We support biotech and phamaceutical companies to focus their drug development on … Type: | 2 | 2 | 0 | 9 |
 | NeoVirTech Virus and viral vector imaging in living cells applied to antiviral discovery and disinfection processes NeoVirTech (NVT) is one of the leading virus imaging and antiviral discovery company in Europe. The company has been highlighted in the Top10 drug discovery companies, Europe, 2019 by the PharmaTechOutlook Magazine. NVT has developed a breakthrough technology to directly visualize and quantify in real time virus/viral vector infection and replication in living cells, from high resolution to high content imaging. At NeoVirTech, we believe everyone can have access to state-of-the-art virology techniques. We are focusing our activities on antiviral discovery, study of oncolytic and … Type: | 13 | 3 | 6 | 7 |
 | ORTHOPUS Handitech solutions for everyone 🦾 ORTHOPUS is a high-impact start-up that designs innovative and accessible robotic assistants for people with motor disabilities. Founded by David Gouaillier, co-creator of the NAO robot, ORTHOPUS is at the crossroads of technology and solidarity. The company has been awarded the "Entreprise solidaire d'utilité sociale" label, and its aim is to democratise access to assistive technologies. The team of robotics engineers is developing a range of exoskeletons and robotic arms dedicated to arm mobility. Open source hardware, frugal innovation, assistive devices, arm mobility, robots, and technology Type: | 25 | 11 | 20 | 20 |
 | ODONTELLA [Automatic translation follows] The company has filed patents relating to the use of Odontella, the world's first marine microalgae authorized for human consumption. These patents concern the formulation, based on the marine microalgae Odontella, of a wide range of new agri-food products, healthy for the whole family. (Beverages, ready meals, etc.) The company is working on a new value chain, based on Odontella, by developing the first marine plant-based salmon that can directly replace the consumption of farmed salmon, in terms of taste, appearance, texture, nutritional quality and also price. This patented product developed in partnership with specialized laboratories is … Type: | 3 | 2 | 0 | 2 |
 | HYPREVENTION Strutplasty pioneer, address fragile bone. Founded in 2010 by Cécile Vienney (CEO) and 3 orthopedic surgeons, Hyprevention is a French start-up located in France that develops, manufactures and markets implantable medical devices to reinforce weaken bone by osteoporosis or cancer thanks to the STRUTPLASTY® Technology. In 2021, Hyprevention INC was established in New-York - USA to promote V-STRUT© Vertebral Implant FDA cleared. www.hyprevention.com www.hypreventionusa.com V-STRUT© Vertebral Implant is indicated to treat vertebral fractures. The device is made of PEEK polymer, close to normal bone, and presents a pedicle anchorage to reinforce the full vertebrae. It is a unique solution on … Type: | 1 | 1 | 0 | 10 |
 | Rondol Group We created Rondol Industrie in 2012 with the goal of adapting Hot Melt Extrusion (HME) technology to the micro scale and to pharma standards and contributing therefore to better and cheaper healthcare. We are now HQ'd in Nancy, France. Rondol is a privately owned Deeptech company which patented the All-in-One Vertical twin screw extruder, representing a significant innovation in pharmaceutical manufacturing due to its capacity to increase the efficiency of drug formulation and delivery, and allowing for more effective therapeutic solutions. What sets this technology apart is its ability to handle complex formulations, enhance drug solubility, and improve bioavailability. These … Type: | 10 | 2 | 7 | 12 |
 | LABORATOIRES AXAMED SA [Automatic translation follows] HealthCare Innovation Partner Based in Paris, Laboratoires AXAMED®, have a strong capacity for innovation, specializing in the design, development, and marketing of innovative health products in the vast field of family health, electronic self-diagnosis for medical use, prevention and treatment of pain, family hygiene, well-being, and innovative food supplements sold under the NovaBoost® brand. The innovative medical products and devices designed by Laboratoires AXAMED® integrate technology and design and are focused on needs and uses. Laboratoires AXAMED® products provide comfort of use and well-being for patients/users. health, medical devices, prevention and treatment of pain, pharmaceutical, electronic self-diagnosis, … Type: | 0 | 0 | 0 | 12 |
 | SOS ADDICTIONS [Automatic translation follows] To speak differently, to act differently. #addictions #opioids #cannabis #cocaine #tobacco #vape #RdR #alcohol #drugs #medication #ecig #screens #sex Type: | 7 | 1 | 1 | 8 |
 | Enterome Delivering the promise of immunotherapy Enterome is a clinical-stage biopharmaceutical company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Enterome’s pioneering approach to drug discovery is based on its unique and powerful bacterial Mimicry drug discovery platform, which allows it to analyze and uncover new biological insights from the millions of gut bacterial proteins in constant cross-talk with the human body. The company is currently developing a pipeline of drug candidates consisting of OncoMimicsTM peptide-based immunotherapies for the treatment of cancer. EO2463 is in a Phase 2 clinical trial for indolent non-Hodgkin lymphoma, demonstrating a benign … Tags: FrenchTech2030 Type: | 15 | 6 | 9 | 61 |
 | NEBULA Transforming Drug Target Discovery with Physics-Based dataset-free genAI Partnerships At NEBULA, we revolutionize drug discovery by providing a comprehensive, physics-based dataset-free genAI solution for mapping the full range of therapeutic target conformations. Unlike traditional drug development focused on small molecule screening, our innovative approach delves deep into the dynamic nature of macromolecular targets—proteins, mRNA, antigens—unveiling their multitude of physiological conformations. Our dataset-free technology integrates generative genAI with molecular dynamics, rooted in physical principles, to generate an exhaustive profile of potential target structures without relying on pre-existing data. By enhancing the understanding of drug targets, we empower pharmaceutical and biotech companies … Type: | 4 | 0 | 1 | 4 |
 | Serendip innovations Development of a nanoparticulate drug delivery system. The high index of modularity allows custom design of medicines. Serendip innovations is a preclinical-stage biotechnology company developing an innovative nanoparticulate delivery system for active ingredients. We offer co-development partnerships and licensing of our nanotechnology for applications such as therapeutic and prophylactic vaccination or precision therapies. Our unique value proposition lies in the platform's high degree of modularity, enabling us to custom-design a new class of drugs. As a first application, Serendip aims to tackle the challenges of therapeutic vaccines in oncology by turning the platform into a high-performance immunization system to potentiate … Type: | 4 | 1 | 0 | 10 |
 | Kinathera develop first-in-class oral drugs for autoimmune diseases. Kinathera is a seed stage preclinical biotech on a mission to develop unique series of newly patented, orally delivered small chemical molecules to treat patients suffering from immuno-inflammatory disorders. Selective inhibition of our most advanced target, simultaneously: 1, blocks intracellular cascade of the ICOS receptor which control maturation of the humoral response and 2, inhibits type 1 interferon production, a master regulator of BAFF expression and demonstrated component of auto-immune diseases. Activity of Kinathera’s compound on two key immune paths promises enhanced control of hyperactive immune reaction in auto immune or GvHD indications. … Type: | 2 | 2 | 0 | 3 |
 | Kapto Medical SAS Confident clot retrieval Introducing a clot adhering coating that is easily applied to medical devices to improve clot capture and retrieval. Type: | 0 | 0 | 0 | 2 |
 | Olatec Therapeutics Leading the Development of Specific NLRP3 Antagonists, Mediator of Innate Inflammatory Response Olatec is a privately held biopharmaceutical company developing a platform of safe, oral NLRP3 antagonist therapeutics, to treat and prevent a broad spectrum of acute and chronic inflammatory diseases that are known to be mediated by Interleukin-1 (IL-1), including: arthritis, heart failure, asthma, Alzheimer’s disease, multiple sclerosis, type-2 diabetes, melanoma and breast cancers, among others. By selectively targeting NLRP3, the body’s first line response in the innate immune system, Olatec’s lead compound, dapansutrile (lab code: OLT1177®) inhibits the production of pro-inflammatory cytokines IL 1B and IL 18. Olatec’s … Type: | 0 | 0 | 0 | 15 |
 | PREMSTEM The brain injury in the premature born infant: stem cell regeneration research network PREMSTEM is a collective of world leading clinicians, researchers, stakeholder advocacy groups and an industrial partner with well-established experience in neonatology and drug development. We are developing a new regenerative stem cell therapy to repair the brain injury caused by premature birth, also known as encephalopathy of prematurity (EOP). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874721. Posts and results reflect the author’s view only. The European Commission is not responsible for any use that … Type: | 0 | 0 | 0 | 1 |
 | Soihtu DTx Alleviating depression with a ground-breaking, game-based digital therapeutics. After more than a decade of academic research on neuroscience-driven digital therapeutics using video games as delivery media, Soihtu DTx has developed a breakthrough game-based digital intervention to treat depression. Soihtu DTx’s intervention implements broad-spectrum cognitive training targeted to strengthening executive functions and the underlying fronto-parietal neuronal circuits. Cognitive deficits and fronto-parietal hypoactivity are common behavioral and neuronal symptoms of depression, which the antidepressant and psychotherapeutic treatments do not target at all. Soihtu DTx solution with the unique game-based realization targets this key unmet need. We at Soihtu DTx are a cross … Type: | 0 | 0 | 0 | 9 |
 | PolTREG S.A. Innovative therapies for autoimmune diseases. Global pioneer in cellular therapies based on TREGS cells. PolTREG was established as a spin-off from the Medical University of Gdańsk in order to develop and commercialize patented TREG method. PolTREG is the most advanced company in TREGS cellular therapies worldwide, breakthrough therapies for type 1 diabetes (T1D) and multiple sclerosis (MS). PolTREG has very promising results regarding the safety and efficacy of TREGS therapy (completed phase I/II clinical trials in T1D and phase I in MS), ready for the next phase of trials. The company is after EMA Scientific Advice procedure. Type: | 0 | 0 | 0 | 37 |
 | Rowan Modern computational tools for chemistry We’re developing next-generation computational tools to accelerate chemical research and drug discovery. Type: | 0 | 0 | 0 | 5 |
 | Doron Therapeutics Mobility is a Gift Type: | 0 | 0 | 0 | 5 |
 | Secretome Therapeutics Revolutionizing cell therapy for inflammatory diseases via neonatal cardiac progenitor cells and their secretomes Revolutionizing cell therapy to address inflammatory diseases driven via neonatal cardiac progenitor cells and their secretomes. Type: | 0 | 0 | 0 | 13 |
 | Biolux Technology Our mission is to bring breakthrough technology to the world that has the potential to significantly improve dental care for millions of patients worldwide. We work with technologies that will significantly improve the way dental care is provided and work closely with the manufacturers to help them successfully enter and grow new markets. We aim to educate dentists to change the way they work to make their lives better and improve their business though better technology leading to reduced chair time, improved profitability and increased patient retention. Type: | 0 | 0 | 0 | 15 |
 | Avenue Biosciences Transforming protein biologics with groundbreaking high-throughput protein engineering. Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biology and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, … Type: | 3 | 0 | 3 | 10 |
 | Integrated Biosciences, Inc. Redefining Drug Discovery for Aging and Beyond Our platform is built around a proprietary synthetic biology toolkit, featuring advanced optogenetic tools that enable precise temporal and spatial control of complex pathways and difficult-to-drug targets. Powered by vast proprietary datasets and cutting-edge AI models, our platform accelerates drug discovery and facilitates the generation of novel chemical matter, unlocking solutions for even the most challenging biological systems. biotechnology, aging, drug discovery, machine learning, synthetic biology, optogenetics, artificial intelligence, small molecule, rejuvenation, molecular biology, and novel therapeutics Type: | 1 | 0 | 1 | 10 |
 | MintNeuro Enabling next-generation neural implants with advanced semiconductor technology. We are pioneering the use of semiconductor technology for next-generation neural implants. Our mission is to provide the best possible outcomes for patients with neurological conditions by delivering the highest performance with the least invasive surgery. Our team brings together world-class experts in neuroscience, microtechnology, and implantable neural interfaces — augmented with medtech industry pedigree and clinical experience. Semiconductors, Neural Implants, Brain-Computer Interfaces, Microelectronics, Medical Devices, Neural Interfaces, Neuromodulation, Neuromonitoring, and Neuroprosthetics Type: | 3 | 0 | 0 | 16 |
 | VitroScan Predicting treatment outcome VitroScan is a Dutch biotech company founded in 2016 and based at the Leiden Bio Science Park. We develop certified predictive ex vivo 3D tumor testing services for reliable treatment response prediction for the clinic and to improve patient stratification for clinical trials. Our proprietary technology provides highly reproducible drug testing in the native tumor microenvironment (TME). VitroScan’s clinical trial program is performed in collaboration with expert clinicians from leading oncology centers. In these trials patient specific ex vivo tumor sensitivity to chemo-, targeted, or immunotherapy is correlated to clinical outcomes. We are dedicated to delivering predictive … Type: | 0 | 0 | 0 | 8 |
 | Chromodynamics Taking the guesswork out of drug development At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis Type: | 0 | 0 | 0 | 6 |
 | 1910 Genetics Advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation. 1910 Genetics is the only biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation. We integrate AI with three proprietary data streams – computational data, wet lab proxy biological data, and wet lab ground truth biological data – to deliver novel drug candidates and software solutions to leading pharma and tech partners, and advance our internal pipeline for neurological, autoimmune diseases, and cancer. We are backed by leading investors including M12 - Microsoft's Venture Fund, … Type: | 2 | 0 | 2 | 36 |
 | Archon Biosciences Pioneering next-generation antibody therapies with AI and computational protein design Archon is a biotechnology company developing computationally designed proteins to unlock powerful therapeutic targets that lie beyond the reach of existing modalities and to better treat disease. We directly apply generative protein design to create a new biologic class, Antibody Cages (AbCs), that integrates the industry-proven affinity and specificity of antibodies into self-assembling nanostructures. Precise control over AbC structure provides the ability to tune both how they distribute in the body and engage their cellular targets with high specificity and potency to establish a new gold-standard for biologic medicines. Archon … Type: | 0 | 0 | 0 | 23 |
 | uPATCH Making healthcare available for every person on earth uPATCH aims to accelerate the transition of microneedles from a research environment into real-world, lifesaving solutions. With a size of less than 1 mm, they have proved to be more effective and less intrusive compared to many conventional methods of drug administration; great breakthrough innovations are being achieved around the world every day. The introduction of a standardized application procedure for end users is now begging for attention. Microneedles are, without a doubt, the drug administrative tool of the future. Their size reduces pain and chances for infections, while simultaneously removing the … Type: | 0 | 0 | 0 | 4 |
 | Wave Therapeutics a new wave of comfort and health. Wave Therapeutics, a Techstars company, has developed disruptive smart cushioning technology designed to prevent bedsores, save lives, and reduce a huge cost center for long-term and acute care facilities. Our devices help reduce the risks of bedsores and blood clots through a unique combination of tested medical therapies combined with powerful analytics capabilities. Using our technology healthcare facilities can reduce hospitalization stays and treatment costs, increase reimbursements, and eliminate crippling legal liabilities. Our technology is affordable, works better than anything else on the market, and has medical, consumer, and even military application with … Type: | 0 | 0 | 0 | 9 |
 | Talus Bio Gene regulator profiling in live cells for drug development Talus Bioscience is a venture-backed early-stage biotechnology startup company working on drug development for gene regulators. Talus Bio spun out of two leading institutions in September 2020 (University of Washington and Altius Institute for Biomedical Sciences) and is located in Seattle, WA. We are building a data-enabled drug development platform that will focus primarily on small-molecule drug development in oncology. Talus Bio's platform measures a drug’s ability to disrupt a gene regulator within its natural, non-engineered cellular environment. Furthermore, a single experiment using the platform measures activity for about 1,000 gene … Type: | 2 | 1 | 1 | 23 |
 | VerImmune Redirecting Immune Memory from Pathogens or Childhood Vaccines to Target Cancer VerImmune is advancing Anti-tumor Immune Redirection (AIR): A Breakthrough Therapy that Redirects Pre-Existing Immune Memory from Childhood Vaccination or Infection to Fight Cancer Type: | 0 | 0 | 0 | 13 |
 | Kano Therapeutics Complete genes for complete cures Kano Therapeutics is a founder-led biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them, empowering scientists, labs, and companies with the building blocks they need to cross the chasm to cures. Biotechnology, DNA therapeutics, Gene therapy, CRISPR, and Biological engineering Type: | 0 | 0 | 0 | 16 |
 | CytoTronics Visualize live-cell function at scale. CytoTronics is commercializing technology emerging from the Harvard University labs to bring unique insights to drug discovery. A revolutionary approach to studying cell biology, powered by microchips. Electrophysiology, CMOS, Phenotypic Screening, Electrochemistry, Cell measurement, and Cell manipulation Type: | 0 | 0 | 0 | 30 |
 | eGenesis, Inc. Developing human-compatible organs for transplantation. Transforming Transplantation. 🧬 eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis’ mission is to solve the global organ shortage crisis by developing a scalable alternative to allotransplantation. eGenesis is reinvigorating the field of xenotransplantation by addressing the key virology and immunology hurdles that have prevented its advancement to date, and is developing commercially-viable products to save and improve the lives of patients who are waiting for an organ transplant. Genome Engineering Type: | 3 | 0 | 1 | 107 |
 | CairnSurgical, Inc. Striving to make #breastcancer surgery more precise. Enrolling Now: Breast Cancer Locator System Study CairnSurgical, Inc. is a clinical stage medical device company developing patient-specific surgical guides using patient imaging data and state-of-the-art 3D printing technologies. CairnSurgical’s Breast Cancer Locator System enables precise tumor localization and excision, and has been tested in both single-arm and randomized clinical trials. The Breast Cancer Locator is considered an investigational device in the U.S. and is limited by U.S. law to investigational use only. It is not approved for sale in any region. Medical Devices, Image-guided Surgery, Breast Cancer, Breast Conserving Surgery, and Personalized … Type: | 0 | 0 | 0 | 14 |
 | atbtherapeutics Antibody Bioengineered atbtherapeutics is a pioneering biopharmaceutical company building a new line of attack against cancer. atbtherapeutics has developed the atbody; a game-changer biologic format designed to broaden the therapeutic window of antibody-based therapies. Only our proprietary and versatile plant-based atbiofarm technology enables single-step manufacturing of our novel class of therapeutic atbodies. The resulting therapeutics offer a novel mechanism of action, avoiding major cancer cell resistance, and provide a promising, life-changing therapy for hard-to-treat and refractory cancer. Type: | 1 | 1 | 0 | 20 |
 | Valora Therapeutics, Inc. New Biologics to Unlock the Therapeutic Potential of Glyco-Immune Checkpoint Modulation Valora Therapeutics Inc. (Valora) is a pre-clinical stage biopharmaceutical company based in San Diego, California, USA, pioneering a new biologic platform invented by Nobel Laureate Dr. Carolyn Bertozzi (Stanford). Our proprietary platform technology enables the engineering of chimeric antibodies to unlock new mechanisms of immune signaling and activity, paving the way for transformative therapies in oncology, immune diseases, and beyond. Type: | 0 | 0 | 0 | 10 |
 | NanoVation TherapeuticsTM Delivering tomorrow's genetic medicines, todayTM NanoVation Therapeutics is a pioneer in the design and creation of lipid nanoparticles (LNPs) for nucleic acid delivery. The company’s LNP technologies aim to overcome the limitations of existing nucleic acid delivery approaches, including the ability to target tissues outside the liver (extrahepatic delivery). NanoVation’s lead technology is its proprietary long-circulating LNP (lcLNPTM) platform, which enables functional nucleic acid delivery to extrahepatic cell types and has demonstrated an improved therapeutic index in preclinical studies. NanoVation partners with leading pharmaceutical and biotech companies develop genetic medicines for previously untreatable diseases. NTx is delivering tomorrow's genetic medicines, … Type: | 1 | 0 | 0 | 42 |
 | Cradle Design better proteins. We believe Cells can theoretically produce almost anything, from fabrics to food, fuel and medicines. Designing cell-factories is hard, but our tools and machine-learning models can make it easier. Our mission is to ultimately help replace traditional farms and factories for a more sustainable world. Jobs: https://jobs.cradle.bio protein design, machine learning, protein activity, protein stability, protein secretability, protein , protein structure, metabolic engineering, protein engineering, and protein solubility Type: | 4 | 2 | 2 | 72 |
 | Ferment We incubate, fund, and launch new companies that use programmed biology to shape the human future. Ferment is a venture studio building new companies that rapidly translate biology into products that solve targeted problems across industrial and consumer markets including food & nutrition, industrials & waste, materials, consumer health and more. synbio, synthetic biology, biotech, programmed biology, venture studio, company creation studio, incubator, venture capital, biotechnology, industrial biotechnology, and consumer biotechnology Type: | 1 | 0 | 0 | 8 |
 | Predicta Biosciences A precision oncology company integrating multiomics to develop innovative diagnostic and therapeutic products. Predicta Biosciences is a precision oncology company integrating cutting edge multiomics and liquid biopsies to develop innovative diagnostic and therapeutic products. Predicta's diagnostic product portfolio removes the burden of bone-marrow biopsies, through small blood-based samples, and enables best-in-class treatment decision-making for immunotherapies. Utilizing the data from the diagnostic platform, Predicta has an in-house therapeutic pipeline of novel immunotherapy targets in pre-clinical discovery and development. Type: | 0 | 0 | 0 | 7 |
 | Syntropic Syntropic develops novel new treatments for psychiatric disorders. Syntropic is a clinical stage medical device company developing new technologies that enhance the brain’s neuroplasticity, allowing for the treatment of psychiatric disorders and the improvement of cognition. Type: | 1 | 0 | 1 | 9 |
 | Outpace Bio Revolutionizing Cell Therapy with Protein Design Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy (OutLastTM), recruit a productive immune response in the tumor microenvironment (OutSmartTM), and achieve the potency (OutSpacersTM), specificity (Co-LOCKRTM), and safety (EGFRoptTM) necessary to unlock diverse cancer indications. Outpace’s internal and partnered pipeline approach is optimized for rapid clinical validation of … Type: | 1 | 0 | 1 | 61 |
 | Cell BioEngines, Inc ‘Off-the-Shelf’ Curative Cell Therapies About Us: Cell BioEngines, Inc., founded in Dec 2022, is a clinical-stage biotech company focused on developing allogeneic 'off-the-shelf' stem cell and its derived therapies as ‘drugs’ for human disease treatment. The company utilizes a ‘plug-and-play’ proprietary platform technology that transforms universal ‘non-gene-modified’ donor blood stem cells from umbilical cords, to produce high-quality, pure and potent, multiple clinical grade cells at scale. This innovative method aims to make stem cells and its derived therapies more accessible and efficient. Its lead product is currently in Phase 1 trials for the treatment of hematopoetiic neoplasms not curable with … Type: | 2 | 0 | 1 | 3 |
 | Spear Bio The first homogeneous immunoassay platform offering unmatched sensitivity with scalable simplicity. Spear Bio, founded in 2021, is a well-funded and rapidly growing start-up headquartered in Woburn, Massachusetts. Spear Bio’s proprietary technology, Successive Proximity Extension Amplification Reaction (SPEAR), employs a unique 2-factor authentication mechanism to precisely measure protein biomarkers at attomolar levels from sub-microliter sample volumes, enabling unprecedented sensitivity. We are dedicated to revolutionizing early disease diagnosis and monitoring, empowering clinicians and researchers to improve patient outcomes, and advance global health. For more information, please visit www.spear.bio or email info@spear.bio. Biotechnology, Ultra Sensitive Immunoassays, and research Type: | 0 | 0 | 0 | 33 |
 | GRO Biosciences GRObio’s groundbreaking science expands the amino acid alphabet to deliver on the promise of protein-based therapies. GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases. Protein therapeutics, Biologics, and Genomic recoding Type: | 0 | 0 | 0 | 32 |
 | Plonts We create fermented foods that make animal products obsolete. Fermentation was the first human biotechnology to convert simple ingredients into incredible foods: milk into cheese, pork into prosciutto, grains into beer and bread. Plonts (formerly known as Tezza Foods) is a public benefit corporation that discovers and designs microbial communities to transform inexpensive plants into new categories of sustainable fermented foods. This approach allows us to create plant-based foods that are absurdly delicious and less expensive than animal-based counterparts. We are starting with the most resource-intensive and addictive dairy product: 🧀. Founded by two people making it up as they … Type: | 1 | 1 | 0 | 28 |
 | Ionetix Providing full-service radioisotope production and end-to-end radiopharmaceutical manufacturing solutions. Ionetix is a cyclotron and technology company providing full-service radioisotope production and end-to-end radiopharmaceutical manufacturing solutions by actively establishing a network of ION-12SCs installed on or near the campus of PET programs across the country. By covering all costs related to the installation and ongoing operation of the cyclotron and making N-13 Ammonia available to providers through a pay-by-the-dose model, we are making this critical tracer accessible and affordable to providers nationwide. Our more recent endeavors involve leveraging our growing network of radiopharmaceutical manufacturing locations to support the development and commercialization … Type: | 0 | 0 | 0 | 64 |
 | Apriori Bio Apriori Bio is working to create a world where humanity is protected against viral threats. Apriori is working to create a world where humanity is protected against viral threats. Our pioneering approach centers on a unique technology platform, which allows us to survey the entire landscape of existing and potential viral variants to design new vaccines and antibody drugs against the most threatening variants. Octavia can also inform public health policy in real time by predicting the impact of emerging variants. Apriori was founded in 2020 in Flagship Labs, a unit of Flagship Pioneering. Type: | 1 | 0 | 0 | 36 |
 | Sarcura Powering New Possibles in Cell Therapy Manufacturing Cell therapy has transformed cancer treatment, yet the hurdles of manufacturing patient-derived cell therapies remain a formidable challenge for the industry. Quality and scalability problems lead to high therapeutic costs and limit access to those life-saving treatments. By harnessing the power of cutting-edge semiconductor technologies, including silicon photonics seamlessly integrated into microfluidic cartridges, Sarcura is orchestrating a transformative shift. Central to Sarcura's mission is the creation of fully automated manufacturing systems endowed with real-time process and product control. This pioneering platform promises to usher in a new era of cost-effective and secure cell … Type: | 1 | 0 | 0 | 30 |
 | MedicalGroup Implant Coating Experts MedicalGroup is a contract manufacturing partner for orthopaedic, spinal and dental implant companies around the world, since 1989, Our activities, all ISO 13485 certified, offer global solutions : Powder : manufacturing of Hydroxyapatite powder for plasma spray, biologics, lab analysis, 3D Printing Coating: metallic (Ti and CrCo) and ceramic (HA and alumina) coatings of medical devices (MasterFile for US market) Packaging: cleaning and packaging of medical and surgical devices Lab: microbiological and physico-chemical analysis. Biomaterials and bone substitutes for orthopaedic and dental applications Revêtements métallique et ceéramique sur dispositifs médicaux implantables, Poudre d'Hydroxyapatite, sous-traitant orthopédique, and Nettoyage … Type: | 0 | 0 | 0 | 60 |
 | Akron Bio Powering the future of medicine Since 2006, Akron’s mission is to provide GMP-compliant materials and services that enable innovators to develop and commercialize advanced therapies. Along with its line of GMP quality cytokines, growth factors, blood-derived products, and custom media, Akron specializes in manufacturing custom plasmids and endonucleases to support viral vector and gene editing technologies. Akron’s newly opened 110,000 sq. ft. manufacturing facility operates in line with FDA 21 CFR Part 11 and Eudralex Vol 4 Annex 11 standards. Akron provides advanced therapy developers the scale, compliance, flexibility, and regulatory support to develop novel technologies from pre-clinical through to … Type: | 1 | 0 | 0 | 112 |
 | Benhur [Automatic translation follows] "The best ally for your company" We help you through digital marketing to reach another level! Type: | 4 | 2 | 2 | 51 |
 | Suomen Punainen Risti, Veripalvelu [Automatic translation follows] The Finnish Red Cross Blood Service provides hospitals with safe and effective blood products and laboratory services needed for patient care. We collect blood from voluntary blood donors according to the needs of patient care. We also provide hospitals with services supporting stem cell and organ transplantation. The Blood Service is a non-profit organization. Our annual budget is approximately 60 million euros and we employ approximately 500 people. We are part of a unique chain of assistance with donors and healthcare personnel. blood products, laboratory services, stem cell and tissue services, cell therapies and research, research and … Type: | 1 | 1 | 0 | 208 |
 | POWERGYM Sport Nutrition [Automatic translation follows] Experts in Premium Quality Supplementation and Sports Nutrition, with more than 30 years of experience. Specialists, since 1991 being experts in premium quality supplements and sports nutrition. We are the only manufacturers nationwide, who design our products under high pharmaceutical quality standards, proof of this being the certifications obtained by the facilities where we develop and produce our entire range of supplementation and sports nutrition. Through scientific research our formulations exceed the expectations of our consumers. We develop Premium supplements for different objectives, such as: + Endurance + Fitness + Performance + Recovery POWERGYM: The Nutrition Science … Type: | 0 | 0 | 0 | 12 |
 | FARMALIDER Driving Innovation in Health At Farmalider, we believe in ideas as a driving force for progress. We know that true innovation comes from merging a brilliant idea with the ability to transform it into real improvements in people's health. As a pioneering strategic partner in pharmaceutical innovation, we offer a comprehensive service that spans from ideation and development to intellectual property, licensing, manufacturing, and supply. Our commitment to continuous improvement, solid knowledge, and adaptability allows us to make a difference every day, building sustainable relationships with our clients. For this reason, we offer both prescription and over-the-counter pharmaceutical products, patents, … Type: | 3 | 0 | 3 | 99 |
 | CAP COMPLIANCE [Automatic translation follows] CONSULTING, AUDIT, SPECIALIZED TRAINING HEALTHCARE INDUSTRY - medical devices, cosmetics, food supplements, med. CAP COMPLIANCE – Your Expert in Regulatory Affairs and CE Marking for Medical Devices CAP COMPLIANCE is a consulting company dedicated to manufacturers of medical devices and in vitro diagnostic medical devices, specializing in regulatory support, training, auditing and compliance with current requirements. Our mission is to support you in each key step of regulatory management, from setting up quality management systems to obtaining CE marking, while ensuring continuous adaptation to evolving standards. We work closely with medical device manufacturers to ensure that their … Type: | 3 | 2 | 3 | 7 |
 | CEMA Technologies Technologies for Efficient Tooling For more than 50 years we manufacture multi-cavity molds (>128) for drug delivery devices. plastique, moule d'injection, injection mold, medical, diagnostic, pharmaceutical, design control, and metrology Type: | 6 | 1 | 3 | 38 |
 | TECH4HEALTH [Automatic translation follows] Supporting health technologies throughout their maturation cycle. A network of expertise composed of responsive platforms, which answer the "Why, When and How to carry out preclinical and clinical studies". The network aims to encourage initiatives and facilitate the realization of multidisciplinary and collaborative translational research projects in the field of the evaluation of medical devices, e-Health and biomaterials. It is a national network bringing together academic expertise in regulation and evaluation for the development of medical devices, e-Health and biomaterials throughout their life cycle. These axes may be expanded according to the needs, strategic issues and resources … Type: | 1 | 1 | 0 | 3 |
 | Bionoveo [Automatic translation follows] Health Research & Development Center BIONOVEO offers project leaders, industrial or academic, the biological, technical and methodological skills and resources necessary for the development of new therapeutic and diagnostic strategies, as well as their production processes. Type: | 4 | 2 | 4 | 3 |
 | MEDICAL EXPANSION MEDICAL EXPANSION is a consultancy specialized in supporting the international development of small to medium sized enterprises in the sector of HEALTHCARE. Whether you are in OTC, medical devices, biotech, nutritional supplements, or natural health products, we can bring you tailor-made support and solutions and will obtain tangible results to fulfil your international ambitions. We can deliver on this promise thanks to more than 18 years of experience in international development, with the support of a network of expert associates specialized in healthcare marketing. If you have the will, we have the experience and know-how. So just give us a … Type: | 1 | 1 | 0 | 4 |
 | COLTENE Micro-Mega [Automatic translation follows] 🇬🇧 French designer and manufacturer since 1905 💪 For dental professionals | 🌍 Global supplier The MICRO-MEGA company, whose original activity dates back to 1905, is recognized worldwide for the design, manufacture and marketing of medical devices intended for dental surgery. Its root canal and obturation instruments, its handpieces and contra-angles and its hygiene devices demonstrate its unique technical and scientific know-how and the impeccable quality of its endodontic products made in France. medical, dentistry, dentaire, and endodontie Type: | 9 | 1 | 4 | 91 |
 | Asdia [Automatic translation follows] The patient at the heart of our concerns The patient at the heart of our concerns ASDIA was founded in Strasbourg in 2002 in the premises of the European Center for the Study of Diabetes (CEED), a research structure aimed at developing innovative therapies that could alleviate or even cure diabetes in the future. This proximity has deeply influenced our business approach, dedicated to supporting patients in their daily lives, while keeping an eye on their future. Building on this ongoing commitment to patient education and monitoring to ensure the effectiveness of their treatments, we have gradually … Type: | 7 | 1 | 6 | 473 |
 | Santélys [Automatic translation follows] Finding a solution at home, regardless of the age, level of dependency and state of health of patients. Recognized as being of public utility, Santélys is a non-profit institution specializing in health, home care and training. Coordination, prevention, education, hospitalization, care, support, technologies, telemedicine and remote monitoring, at home and in a local unit: Santélys' vocation is to find a solution at home, regardless of the age, level of dependency and state of health of the patient suffering from a chronic illness (renal failure, respiratory failure, diabetes, etc.) or cancer. Nursing training, training of nursing assistants, continuing … Type: | 4 | 2 | 3 | 485 |
 | AURAL Alsace [Automatic translation follows] Progress 🚩and innovate🚀 Cooperate and commit to humanity HISTORICAL Created in 1972 by Professor JAHN, Head of the Nephrology and Hemodialysis Department at the Strasbourg University Hospital, AURAL is a non-profit association offering all treatment modalities for chronic renal failure as well as home hospitalization and is present throughout the Alsace region. The HAD activity began in May 2004. In 1981, AURAL started Continuous Ambulatory Peritoneal Dialysis. The first assisted AD units were set up in 1985, and in 1996, the UMs. The DPA was created in 1994, and allows young patients to continue a professional activity … Type: | 2 | 2 | 0 | 141 |
 | GMED [Automatic translation follows] GMED is a French certification body and notified body in Europe (identification number 0459). GMED is a French certification body and notified body in Europe (identification number 0459). It is responsible for assessing the conformity of medical devices according to the applicable European directives (90/385/EEC, 93/42/EEC and 98/79/EC). Accredited by the French Accreditation Committee COFRAC (under certificate No. 4-0608), in accordance with the NF EN ISO/CEI 17021: 2015 standard, GMED carries out quality management system certification activities according to ISO 9001: 2015 and ISO 13485: 2016 standards. GMED is also an audit body recognized by the MDSAP … Type: | 13 | 3 | 10 | 258 |
 | HC NEXT Expert en gestion de projet de développement de produits de santé innovants HC NEXT is a consulting company expert in project management and vendor management for drug and medical device development! HC NEXT’s mission is to speed up and derisk drugs and medical devices developments to ensure that each innovation becomes a product to patient’s benefit. HC NEXT consultants are both project management specialists and generalists in the field of healthcare product development. We kindly but seriously challenge habits, routine, bias, status quo, prejudices. Dare to be different! Dispositif médical, Médicament, Gestion de Projet, Développement, CMC, Qualité, Réglementaire, COO, and … Type: | 4 | 1 | 4 | 3 |
 | MBCP® Technology (Advanced Medical Solutions) experts in bone regeneration Biomatlante is a specialist in synthetic biomaterials promoting bone regrowth and the precursor of bone substitute technologies. We market our products for orthopedic, trauma, spine, ENT, stomatological and dental surgery in more than 50 countries. Our Mission Develop and promote the proprietary MBCP® Technology as the scaffold of reference in any bone regeneration solution for best-in-class patient care. Our Vision Bone surgeries often demand grafts for which autograft is considered as the gold standard in terms of tissue regeneration performance and limited rejection risk. Autograft is available in limited quantity though, and harvesting methods are expensive … Type: | 3 | 1 | 3 | 33 |
 | HBR Innovation [Automatic translation follows] "If you take care of your employees, they will take care of your company" (R. Branson) Do you want to improve the working conditions of your employees? You have already identified, in your company, positions with physical constraints and where you encounter problems of Musculoskeletal Disorders (MSDs). Are you wondering if exoskeletons are the solution for your company/establishment? Do not hesitate to contact us at: e-mail: contact@hbrinnovation.fr Tel: 05 56 14 30 56 We will analyze the workstations together in order to find the most relevant solution for your organization. What is an exoskeleton? It is a … Type: | 1 | 1 | 0 | 1 |
 | InSiliBio We use innovating solutions to test molecules through original bioinformatic methods. Our proposed methods are fully eth InSiliBio is a revolutionary contract research organization (CRO). We use innovating solutions to test molecules through original bioinformatic methods. Within the perspective of developing novel products and formulations, cosmetic, pharmaceutic and food companies undertake long research (up to several years), with expensive investments. These experiments often provide only fragmented information. These trials are sometimes being conducted on living organisms (animals, human cell etc. ), which are increasingly questioned from an ethical standpoint. Our proposed methods are fully ethical, fast, reliable and cost-effective. Our … Type: | 19 | 11 | 11 | 7 |
 | Hybrigenics Services Expert in target deconvolution for drugs, protein-protein interactions and single-domain antibodies Who else knows your drug or protein better than you? Who else knows protein interactions better than us? Hybrigenics Services is a complete solution provider of cutting-edge technologies dedicated to the study of protein interactions and target identification for drugs. We are also proud to now offer a unique, proprietary nanobody selection service. We help researchers: - Understand proteins' functions through the elucidation of their interactions - Characterize precisely a known interaction (map critical domains or amino-acids...) - Identify the targets of small molecules of therapeutic interest - Predict … Type: | 8 | 2 | 7 | 35 |
 | iSTAR Medical Developing innovative ophthalmic implants made from proprietary STAR® material to improve the lives of patients. About iSTAR Medical iSTAR Medical is committed to delivering breakthrough eye care solutions. Our most advanced product, MINIject, is approved in Europe for the treatment of open-angle glaucoma – the leading cause of irreversible blindness[1] – and we are aiming to seek market approval in the US. About MINIject® MINIject is iSTAR Medical’s innovative MIGS device for patients with primary open-angle glaucoma. MINIject combines the unique porous structure of its proprietary STAR material with the power offered by the supraciliary space. As a result, it … Type: | 5 | 2 | 1 | 59 |
 | Nyxoah The Path to Restful Nights Nyxoah is a pioneering medical device company developing a breakthrough therapeutic solution for the treatment of Obstructive Sleep Apnea (OSA). Our mission is to become a world leading company by offering unique patient-centric neuromodulation solutions, developed by passionate and exceptionally driven people Nyxoah's therapy Genio® offers: - Unparalleled clinical efficacy - Increased patient comfort, therapy compliance and quality of life - Minimally invasive approach, thus streamlining patient flow and reducing surgery related risks - Positive health economics outcomes by reducing the burden of OSA and its comorbidities Neurostimulation and Obstructive Sleep Apnea (OSA) Type: | 5 | 3 | 2 | 171 |
 | NOVADIP Biosciences S.A. Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform. Novadip Biosciences is a clinical-stage biopharmaceutical company founded to design, develop, and bring to the market a new class of regenerative tissue products to accelerate healing of large bone defects and injuries in a single treatment. Novadip’s lead allogeneic product, NVD-X3, employs a matrix containing multiple bioactive factors that induce accelerated tissue healing. Designed as an “off-the-shelf” product, NVD-X3 can be shipped and stored at room temperature and offers superior intraoperative handling characteristics. Novadip is also developing NVD-003, an autologous therapy derived from ASCs as … Type: | 6 | 3 | 3 | 53 |
 | Immunovia AB Advancing early detection of pancreatic cancer Immunovia AB is a diagnostic company that is developing and commercializing highly accurate blood tests for the early detection of cancer and autoimmune diseases based on Immunovia’s proprietary test platform called IMMrayTM. Tests are based on antibody biomarker microarray analysis using advanced machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a unique “disease biomarker signature”. The company was founded in 2007, based on cancer studies and ground-breaking research in the Department of Immuntechnology at Lund University and CREATE Health Cancer Center, Sweden. The first product, … Type: | 0 | 0 | 0 | 21 |
 | OssDsign OssDsign is a developer and global provider of next generation orthobiologics products. OssDsign is a developer and global provider of next generation orthobiologics products. Based on cutting edge material science, the company develops and markets products that support the body's own healing capabilities, giving patients back the life they deserve. Website: www.ossdsign.com Newsroom: https://news.cision.com/ossdsign-ab (Always consult Instructions for Use which accompany the products for complete indications, contraindications, warnings and precautions.) Medical devices, Bone regeneration, Bonegraft, Orthopaedic surgery, Spine surgery, and Orthobiologics Type: | 2 | 0 | 2 | 37 |
Startup